GPP
Great Point Partners’s Iovance Biotherapeutics IOVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-930,000
| Closed | -$29.4M | – | 32 |
|
|
2021
Q1 | $29.4M | Buy |
930,000
+12,573
| +1% | +$398K | 6.09% | 3 |
|
|
2020
Q4 | $42.6M | Sell |
917,427
-2,959,173
| -76% | -$137M | 6.91% | 2 |
|
|
2020
Q3 | $128M | Buy |
3,876,600
+151,624
| +4% | +$4.99M | 11.48% | 1 |
|
|
2020
Q2 | $102M | Buy |
3,724,976
+1,337,370
| +56% | +$36.7M | 8.17% | 2 |
|
|
2020
Q1 | $71.5M | Sell |
2,387,606
-2,627,569
| -52% | -$78.7M | 7.47% | 4 |
|
|
2019
Q4 | $139M | Sell |
5,015,175
-245,628
| -5% | -$6.8M | 12.09% | 1 |
|
|
2019
Q3 | $95.7M | Hold |
5,260,803
| – | – | 8.8% | 1 |
|
|
2019
Q2 | $129M | Sell |
5,260,803
-306,545
| -6% | -$7.52M | 14.32% | 1 |
|
|
2019
Q1 | $52.9M | Hold |
5,567,348
| – | – | 5.24% | 6 |
|
|
2018
Q4 | $49.3M | Buy |
5,567,348
+2,071,008
| +59% | +$18.3M | 6.23% | 2 |
|
|
2018
Q3 | $39.3M | Buy |
3,496,340
+10,595
| +0.3% | +$119K | 6.13% | 4 |
|
|
2018
Q2 | $44.6M | Buy |
3,485,745
+164,572
| +5% | +$2.11M | 6.18% | 3 |
|
|
2018
Q1 | $56.1M | Buy |
3,321,173
+1,321,173
| +66% | +$22.3M | 8.34% | 1 |
|
|
2017
Q4 | $16M | Hold |
2,000,000
| – | – | 2.73% | 16 |
|
|
2017
Q3 | $15.5M | Buy |
2,000,000
+1,830,986
| +1,083% | +$14.2M | 3.02% | 12 |
|
|
2017
Q2 | $1.24M | Buy |
+169,014
| New | +$1.24M | 0.22% | 29 |
|